Merial statement following release of UK government reports on foot and mouth disease outbreak in the UK
September 07, 2007
Merial welcomes the HSE and Spratt reports issued this morning by DEFRA which do not find any biosecurity breach by Merial.
Throughout this period our priority has been to support the authorities to control this outbreak and to determine its cause. With the publication of these reports our focus now is to implement the recommendations made to us.
Merial’s FMD and bluetongue work at its Pirbright centre enables governments and farmers around the world to combat these potentially devastating diseases. As such, in consultation with the appropriate authorities, we look forward to returning to full production.
We would like to commend the investigators for the thoroughness of their work and thank our staff for their commitment and support, especially over the last few weeks when their work has been under such intense scrutiny.
For further information please contact:
Merial is a world-leading, innovation-driven animal health company, providing a comprehensive range of products to enhance the health, well-being and performance of a wide range of animals. Merial employs approximately 5,000 people and operates in more than 150 countries worldwide. Its 2006 sales were nearly $2.2 billion. Merial Limited is a joint venture between Merck & Co., Inc. and sanofi-aventis. For more information, please visit www.merial.com.